Shri Ahimsa Naturals Reports Strong FY26 Results Driven by Volume Growth and Capex Expansion

Shri Ahimsa Naturals Reports Strong FY26 Results Driven by Volume Growth and Capex Expansion​

Shri Ahimsa Naturals Limited (SANL), a leading global manufacturer of Caffeine Anhydrous Natural, announced its audited financial results for the half year and full year ended on March 31, 2026, on May 28, 2026. The company reported robust growth across key financial metrics while also detailing an expanded scope for its ongoing capacity expansion program.

Financial Highlights for FY26​

The company reported significant growth in revenue and profit, driven by strong volume expansion and improved realization.

In the fiscal year 2026, the company's revenue stood at ₹ 123.3 Crs, marking a 29% increase year-over-year (YoY). This growth was primarily attributed to a robust 20% volume increase in Natural Caffeine. Despite elevated freight costs, the company maintained a strong EBITDA margin of 29.1% for FY26. Profit After Tax (PAT) for FY26 increased by 37% YoY, reflecting improvement in the PAT margin.

The balance sheet remains sound, showing low debt and a strong liquidity position. Management noted improvements in working capital metrics, with debtors decreasing to 86 days from 96 days in FY25, and inventory levels improving to 193 days from 214 days in FY25. Cash flow from operations stood at 12 Crs during the period.

The comparative performance snapshot highlights the following year-over-year improvements:

Capacity Expansion and Operational Strategy​

To address anticipated market growth, the company has expanded the scope of its capital expenditure (capex) program. The revised capex plan incorporates the addition of a decaffeination plant, a GCE enrichment plant, fungible manufacturing capacities for other high value botanical extracts, and increased automation.

The new integrated greenfield facility is expected to commence operations by March 2027. Currently, the company's manufacturing capacity for Natural caffeine stands at 270MTPA. For FY26, capacity utilization was 72%, indicating ample scope for incremental utilization to fuel growth in FY27. Furthermore, the company has undertaken multiple process optimization initiatives at its existing facility to enhance operational efficiency and support projected volume growth.

Management Outlook​

Nemi Chand Jain, Managing Director of SANL, stated that the healthy growth in FY26 was fueled by strong volume expansion and improved realizations, which collectively contributed to the robust revenue growth.

Jain emphasized that the strong global demand for core products continues to affirm the company's quality and consistency. Regarding the long-term strategy, he noted that the expanded capex program will strengthen SANL's capabilities. He highlighted that the decaffeination facility, in particular, is anticipated to open new growth avenues and enhance the ability to meet evolving customer requirements across global markets.

Founded in 1990, Shri Ahimsa Naturals Limited is recognized as one of the world's largest manufacturers of caffeine anhydrous natural and green coffee bean extracts. The company operates state-of-the-art manufacturing facilities and exports products to over 25 countries worldwide.

SHRIAHIMSA Stock Price Movement​

On Wednesday, Shri Ahimsa Naturals Limited shares slipped 0.13% to settle at ₹309. The stock saw a volume of 12,000 shares traded and notably achieved its 52-week high of ₹316 during the day's session.